Pharmaceuticals, Biotechnology and Life Sciences
– Dr. Sorensen to become CEO of a start-up hemostasis and thrombosis company –CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE)…
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”)…
Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021WATERTOWN, Mass., July 06, 2021 (GLOBE NEWSWIRE)…
BELTSVILLE, Md., July 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company discovering and developing novel,…
Data demonstrate rapid absorption and higher plasma concentrations versus an intramuscular injection (p<0.0001) Results confirm findings of initial pilot PK…
WATERTOWN, Mass., July 06, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a…
OCALA, Fla., July 06, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it will host…
Company Announcement COPENHAGEN, Denmark; July 06, 2021 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 47,974 shares…
Accelus to Offer Procedure-Enabling Technology with the Goal of Making Minimally Invasive Surgery (MIS) the Standard of Care in SpinePALM…